In an increasingly complex and fast-evolving pharmaceutical landscape, the need for robust competitive and market intelligence (CI/MI) strategies has never been greater. This presentation explores a comprehensive framework designed to elevate CI strategies, offering structured methodologies to gain deeper insights into competitor behavior, market dynamics, and emerging trends—particularly within the European market. By integrating innovative analytical approaches and leveraging high-value intelligence sources, the framework empowers organizations to proactively assess competitor strengths, weaknesses, and strategic directions. Attendees will gain a clear understanding of how to transform raw data into actionable intelligence that supports informed, forward-looking decision-making. In this session, you will learn

• How to elevate your competitive intelligence strategies to gain deeper insights into competitor actions and market dynamics
• What innovative approaches and methodologies can be employed to uncover competitive drivers and identify emerging trends in the European market landscape
• How the proposed framework enhances the process of analyzing competitors’ strengths, weaknesses, and strategic moves to inform proactive decision-making
• Which sources of competitive intelligence yield the most actionable insights, and how can these sources be effectively integrated into existing analytics processes
• What the key challenges and opportunities are in leveraging competitive intelligence to drive innovation and maintain a competitive edge in the evolving market.